Efficacy and Safety of a Personalized Vitamin D<sub>3</sub> Loading Dose Followed by Daily 2000 IU in Colorectal Cancer Patients with Vitamin D Insufficiency: Interim Analysis of a Randomized Controlled Trial
A personalized vitamin D<sub>3</sub> loading dose has not yet been tested in cancer patients. This interim analysis of the randomized, placebo-controlled VICTORIA trial analyzed the first recruited 74 German adults with nonmetastatic colorectal cancer, a tumor surgery within the past yea...
Main Authors: | Sabine Kuznia, David Czock, Annette Kopp-Schneider, Reiner Caspari, Harald Fischer, Dana Clarissa Laetsch, Marija Slavic, Hermann Brenner, Ben Schöttker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/14/21/4546 |
Similar Items
-
Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor - randomized intervention trial
by: Ben Schöttker, et al.
Published: (2020-08-01) -
Prevention of Advanced Cancer by Vitamin D<sub>3</sub> Supplementation: Interaction by Body Mass Index Revisited
by: Hermann Brenner, et al.
Published: (2021-04-01) -
Vitamin D<sub>3</sub> Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals
by: Eva Dědečková, et al.
Published: (2023-03-01) -
A Single Oral Vitamin D<sub>3</sub> Bolus Reduces Inflammatory Markers in Healthy Saudi Males
by: Shareefa A. AlGhamdi, et al.
Published: (2022-10-01) -
A randomized controlled trial of 3 IU Intravenous oxytocin bolus with 7 IU oxytocin infusion versus 10 IU oxytocin intramuscular in the third stage of labor for the prevention of postpartum hemorrhage
by: Shivakumar Pujeri
Published: (2020-01-01)